Brent Pfeiffenberger insider trades

Open-market stock purchases and sales by Brent Pfeiffenberger, President and CEO at Century Therapeutics, Inc, from SEC Form 4 filings since Dec 4, 2023.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +195%.

Recent trades

DateStockTradeValue
Sep 11, 2026IPSC Century Therapeutics, IncSold (not open market)$26.9K
Sep 4, 2026IPSC Century Therapeutics, IncSold (not open market)$977
Aug 14, 2026IPSC Century Therapeutics, IncSold (not open market)$59.9K
Jun 11, 2026IPSC Century Therapeutics, IncSold (not open market)$31K
Jun 5, 2026IPSC Century Therapeutics, IncSold (not open market)$986
May 19, 2026CRBP Corbus Pharmaceuticals Holdings, IncBought (not open market)—
May 19, 2026CRBP Corbus Pharmaceuticals Holdings, IncBought (not open market)—
May 15, 2026IPSC Century Therapeutics, IncSold (not open market)$72.9K
Mar 11, 2026IPSC Century Therapeutics, IncSold (not open market)$151K
Mar 6, 2026IPSC Century Therapeutics, IncSold (not open market)$1.2K
Feb 13, 2026IPSC Century Therapeutics, IncSold (not open market)$54.6K
Feb 2, 2026IPSC Century Therapeutics, IncBought (not open market)—
Feb 2, 2026IPSC Century Therapeutics, IncBought (not open market)—
Dec 12, 2025IPSC Century Therapeutics, IncBought$30.4K
Dec 10, 2025IPSC Century Therapeutics, IncSold (not open market)$244
Nov 19, 2025IPSC Century Therapeutics, IncBought$17.3K
Nov 17, 2025IPSC Century Therapeutics, IncSold$14.7K

Companies traded

  • IPSC Century Therapeutics, Inc: 2 buys, 6 sales, last Sep 11, 2026
  • CRBP Corbus Pharmaceuticals Holdings, Inc: other filings, last May 19, 2026
  • BFLY Butterfly Network, Inc: other filings, last Mar 7, 2024

Get free alerts when Brent Pfeiffenberger files a new trade →